Oncology Active Pharmaceutical Ingredient (API) Market Size & Share, by APIs (Innovative Oncology APIs, Generic Oncology APIs); Synthesis Type (Synthetic Oncology APIs, Biotech Oncology APIs); Manufacturer Type (Captive, Merchant); Type of Cancer (Breast, Cervical, Lung, Liver, Colorectal) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

Request Free Sample Copy

Report ID: 4213
Published Date: Feb 27, 2023
Report Format: PDF, PPT

Buy Now

Companies Dominating the Oncology Active Pharmaceutical Ingredient (API) Landscape

Merck & Co. Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Pfizer Inc.
Abbott Laboratories
Sun Pharmaceutical Industries Ltd.
Novartis AG
Mylan N.V.
GSK plc
AbbVie Inc.
Teva Pharmaceutical Industries Ltd.
Eli Lilli and Company

Browse Key Market Insights with Data Illustration:

Oncology Active Pharmaceutical Ingredient (API) Market Size & Share, Growth Forecasts 2035

In the News

AbbVie Inc. conducted a survey, Emotional Impact Report, and released the findings from it. This survey included more than 300 chronic lymphocytic leukemia patients that grow out of blood cancer. The survey also offered mental and emotional support to patients living with slow-growing blood cancer.
Abbott Laboratories to emerge in a study published in the Lancet Neurology to elaborate on the capability of two blood-based biomarkers to predict the results from traumatic brain injury (TBI) and inform treatment interventions.

Frequently Asked Questions (FAQ)

Higher prevalence of cancer across the globe and the mounting geriatric population is estimated to majorly boost the market growth.

The market is anticipated to attain a CAGR of ~7% over the forecast period, i.e., 2023-2035.

Possibilities of side effects and higher price associated with the manufacturing procedure is estimated to challenge the market growth.

The market in the North America region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Merck & Co. Inc., Pfizer Inc., Abbott Laboratories, Sun Pharmaceutical Industries Ltd., Novartis AG, Mylan N.V., GSK plc, AbbVie Inc., Teva Pharmaceutical Industries Ltd., Eli Lilli and Company, and other key players.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue-generating capacity as well as the new products being launched into the market by the company.

The market is segmented by APIs, manufacturing type, type of cancer, synthesis type, and by region.

The breast cancer segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

Companies Dominating the Oncology Active Pharmaceutical Ingredient (API) Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What are the major factors driving the growth of the oncology active pharmaceutical ingredient (API) market?

What would be the CAGR of oncology active pharmaceutical ingredient (API) market over the forecast period?

What are the challenges affecting the oncology active pharmaceutical ingredient (API) market growth?

Which region will provide more business opportunities for growth of oncology active pharmaceutical ingredient (API) market in future?

Who are the major players dominating the oncology active pharmaceutical ingredient (API) market?

How are the company profiles selected?

What are the segments in the oncology active pharmaceutical ingredient (API) market?

Which segment captures the largest market size in type of cancer segment in the oncology active pharmaceutical ingredient (API) market?